Novo Nordisk Obesity Drugs Sales Slow – Compounders Still Selling illegally
August 6, 2025 Sales of Novo Nordisk’s injectable diabetes drugs including Ozempic have slowed sharply amid fierce competition and the threat of U.S. tariffs, coupled
Noom To Offer GLP-1 Microdose Plan
August 5, 2025 Noom is not giving up in the fight to provide GLP-1 drugs, despite pressure from Novo and Eli Lilly to stop selling
Medifast Reports Q2 Results – Slide Continues
August 4, 2025 “We are working diligently to transform our business as we look to help more people achieve optimal metabolic health,” said Dan Chard,
How Are Weight Loss Surgeons Coping With Less Surgeries?
July 8, 2025 There is no doubt that the number of weight loss (bariatric) surgeries has fallen, due to the competition from the GLP-1 drugs,
Weight Watchers Expands Collaboration With Novo Nordisk
July 2, 2025 Weight Watchers announced an expanded collaboration with Novo Nordisk, which includes increased access to authentic, FDA-approved Wegovy® (semaglutide) injection through Weight Watchers
Novo Nordisk Ends Wegovy Sales Deal With Hims & Hers
June 24, 2025 Hims & Hers stock plummeted nearly 35% Monday after Novo Nordisk announced it was ending a collaboration to make its blockbuster weight-loss
Weight Watchers Reorganization Plan Confirmed
June 18, 2025 Following approval of its Plan of Reorganization, WW is on track to exit the court-supervised financial reorganization process as early as next
Weight Watchers Reports Q1 Results
May 6, 2025 WW management reported first quarter 2025 results today. “We are making progress on our strategic priorities with continued momentum in our Clinical